Nobuhiro Tsukada
Tokyo, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 114 publications
Prognostic factors of 10-year survival in patients with myeloma after autologous stem cell transplantation: a multicenter retrospective analysis.
Journal: Leukemia & lymphoma
Published: August 23, 2026
Pre-CAR-HEMATOTOX at Leukapheresis Predicts Delayed Platelet Recovery After Idecabtagene Vicleucel in Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: June 15, 2026
Response-adapted lenalidomide-dexamethasone (LenDex) intensification after CyBorD induction for transplant-eligible multiple myeloma: the PIANO study.
Journal: Blood research
Published: April 11, 2026
Real-world outcomes of idecabtagene vicleucel in relapsed/refractory multiple myeloma: A single-centre experience.
Journal: British journal of haematology
Published: January 28, 2026
Impact of Intensive Cyclophosphamide-Containing Multi-Agent Bridging Therapy on Outcomes after Idecabtagene Vicleucel in Multiple Myeloma.
Journal: Transplantation and cellular therapy
Published: January 19, 2026
Constrictions and shear stress are key determinants of amyloidogenic light chain (AL) amyloidosis.
Journal: The FEBS journal
Published: January 14, 2026
Prognostic significance of cardiac biomarkers in patients with AL amyloidosis treated with a daratumumab-based regimen.
Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: January 06, 2026
Treatment Discontinuation After Achieving MRD Negativity in Multiple Myeloma in the Pre-BCMA Era: A Prospective, Single-Centre Study.
Journal: EJHaem
Published: January 03, 2026
Correction: JSH practical guidelines for hematological malignancies, 2023 III. Myeloma 1. Multiple myeloma (MM).
Journal: International journal of hematology
Published: December 08, 2025
Outcomes of elranatamab in relapsed/refractory multiple myeloma: prognostic impact of monocyte count, MyCARe, and R2-ISS.
Journal: International journal of hematology
Published: September 27, 2025
Successful management of cardiac arrest due to cytokine release syndrome following chimeric antigen receptor T-cell therapy for multiple myeloma
Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology
Published: September 03, 2025
Last Updated: 09/26/2026